12. februar 2020

Aidian’s SIBA® technology is ideal for assay development of a rapid test for detection of the novel coronavirus (2019-nCov).

Name: Aidian
Price range: $

The Head of Assay Development & IPR Mirko Brummer attended the Prinse’20 Industry Seminar on Printed Intelligence January 29-30, 2020 in Oulu, Finland. There he had the opportunity to present Aidian’s activities relating to the development of a rapid test for the detection of the novel coronavirus (2019-nCoV) that recently emerged in Wuhan, China. Aidian’s SIBA® technology is ideally suited for the rapid development and deployment of tests to sites where testing time needs to be limited to an hour or less, like airports or seaports. Aidian is actively looking for collaborations on SIBA® technology, including coronavirus testing.

Tick season is here

Point of care creatinine and eGFR shows accuracy and could help reduce contrast-induced acute kidney injury

How CRP point of care testing aids primary care and guides sustainable use of antibiotics

Tick season is here

Point of care creatinine and eGFR shows accuracy and could help reduce contrast-induced acute kidney injury

Aidian’s SIBA® technology is ideal for assay development of a rapid test for detection of the novel coronavirus (2019-nCov).

Foreslåtte emner

Populære produkter

Siste nytt

Tick season is here

Point of care creatinine and eGFR shows accuracy and could help reduce contrast-induced acute kidney injury

How CRP point of care testing aids primary care and guides sustainable use of antibiotics

Nyheter

Tick season is here

Point of care creatinine and eGFR shows accuracy and could help reduce contrast-induced acute kidney injury

Dette nettstedet bruker informasjonskapsler

Vi bruker informasjonskapsler til å tilpasse innhold og annonser, til å analysere bruken av nettstedet og til å gjøre tjenestene våre bedre.

Nødvendige (Obligatorisk)

Statistikk

Markedsføring